Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium
Zhuo Wan, Lianbi Zhao, Lu Fan, et al.
Theranostics (2019) Vol. 10, Iss. 1, pp. 218-230
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics
Dongbin Yang, Weihong Zhang, Huanyun Zhang, et al.
Theranostics (2020) Vol. 10, Iss. 8, pp. 3684-3707
Open Access | Times Cited: 722
<p>Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate</p>
Juntang Shao, Jennica L. Zaro, Yuxian Shen
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 9355-9371
Open Access | Times Cited: 213
Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy
Jun Wang, Wei Tang, Meng Yang, et al.
Biomaterials (2021) Vol. 273, pp. 120784-120784
Closed Access | Times Cited: 209
Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate
Lana Ginini, Salem Billan, Eran Fridman, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1375-1375
Open Access | Times Cited: 102
Extracellular vesicle‐mediated delivery of circDYM alleviates CUS‐induced depressive‐like behaviours
Xiaoyu Yu, Ying Bai, Bing Han, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 99
Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy
Lin Yan, Mengchao Yan, Zhongtian Bai, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 71
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Ivan V. Zelepukin, Konstantin G. Shevchenko, Sergey M. Deyev
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
The Discovery of Extracellular Vesicles and Their Emergence as a Next-Generation Therapy
Alin Rai, Bethany Claridge, Jonathan Lozano, et al.
Circulation Research (2024) Vol. 135, Iss. 1, pp. 198-221
Closed Access | Times Cited: 19
Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice
Mengying Wei, Xiaotong Gao, Lijun Liu, et al.
ACS Nano (2020) Vol. 14, Iss. 4, pp. 5099-5110
Closed Access | Times Cited: 109
Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy
Tao‐Tao Tang, Bin Wang, Lin‐Li Lv, et al.
Theranostics (2020) Vol. 10, Iss. 18, pp. 8111-8129
Open Access | Times Cited: 103
CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction
Yan Wang, Chaofu Li, Ranzun Zhao, et al.
Theranostics (2021) Vol. 11, Iss. 13, pp. 6315-6333
Open Access | Times Cited: 101
Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy
Hyo‐Suk Kim, Hochung Jang, Haeun Cho, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4435-4435
Open Access | Times Cited: 98
Exosome-based Ldlr gene therapy for familial hypercholesterolemia in a mouse model
Zhelong Li, Ping Zhao, Yajun Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 6, pp. 2953-2965
Open Access | Times Cited: 78
Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI
Tao‐Tao Tang, Bin Wang, Zuo‐Lin Li, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 10, pp. 2467-2483
Open Access | Times Cited: 77
Nucleic acid delivery with extracellular vesicles
Michaela Schulz‐Siegmund, Achim Aigner
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 89-111
Closed Access | Times Cited: 76
Advances in Exosomes‐Based Drug Delivery Systems
Carmen Gutiérrez Millán, Clara Calvo Díaz, José M. Lanao, et al.
Macromolecular Bioscience (2020) Vol. 21, Iss. 1
Closed Access | Times Cited: 75
Targeted delivery of extracellular vesicles in heart injury
Peier Chen, Ling Wang, Xianglin Fan, et al.
Theranostics (2020) Vol. 11, Iss. 5, pp. 2263-2277
Open Access | Times Cited: 73
Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity
Chao Tian, Yanyan Yang, Baochen Bai, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 5, pp. 1328-1338
Open Access | Times Cited: 60
New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction
Zenglei Zhang, Junnan Tang, Xiaolin Cui, et al.
Inflammation (2021) Vol. 44, Iss. 5, pp. 1696-1712
Open Access | Times Cited: 58
Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy
Liangdi Jiang, Yongwei Gu, Yue Du, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 36, pp. 42411-42428
Closed Access | Times Cited: 57
Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances
Zhenggang Wang, Haokun Mo, He Zhiyi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113480-113480
Open Access | Times Cited: 53
Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation
Jessica A. Mills, Feifei Liu, Thomas Ryan Jarrett, et al.
Biomaterials Science (2022) Vol. 10, Iss. 12, pp. 3029-3053
Closed Access | Times Cited: 51
Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design
Haoyue Song, Xiaohang Chen, Yujia Hao, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 47
Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 678-696
Closed Access | Times Cited: 44
Nanobiotechnology: Applications in Chronic Wound Healing
Tao Jiang, Qianyun Li, Jinmei Qiu, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3125-3145
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top